PHIL in the Treatment of Intracranial dAVF.

NACompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 24, 2018

Primary Completion Date

December 12, 2022

Study Completion Date

December 12, 2022

Conditions

Arteriovenous Dural Fistula

Interventions

DEVICE

PHIL® Liquid Embolic System

The PHIL Embolic System is indicated in the treatment of dural arteriovenous fistulas (DAVF)

Trial Locations (1)

Albany Medical Center, Albany

All Listed Sponsors

lead

Microvention-Terumo, Inc.

INDUSTRY

NCT03467542 - PHIL in the Treatment of Intracranial dAVF. | Biotech Hunter | Biotech Hunter